Anti-tumour activity of T cells expressing chimeric receptors which incorporate both primary and costimulatory signalling sequences

被引：0
|
作者：
Lawson, ADG [1 ]
Finney, HM [1 ]
Moser, RN [1 ]
Bergin, M [1 ]
Suitters, A [1 ]
Antoniw, P [1 ]
Eddleston, A [1 ]
Weir, ANC [1 ]
机构：
[1] Celltech R&D Ltd, Slough SL1 4EN, Berks, England
来源：
CANCER GENE THERAPY | 2001年 / 8卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
PD46
引用
收藏
页码：922 / 922
页数：1
相关论文
共 50 条
  • [1] Chimeric receptors providing both primary and costimulatory signaling in T cells from a single gene product
    Finney, HM
    Lawson, ADG
    Bebbington, CR
    Weir, ANC
    JOURNAL OF IMMUNOLOGY, 1998, 161 (06): : 2791 - 2797
  • [2] Anti-Apoptotic c-FLIP Reduces the Anti-Tumour Activity of Chimeric Antigen Receptor T Cells
    Tan, Grace Min Yi
    Poudel, Aarati
    Rad, Seyed Mohammad Ali Hosseini
    McLellan, Alexander Donald
    CANCERS, 2022, 14 (19)
  • [3] A folate receptor alpha specific, CD28/CD40-based chimeric costimulatory antigen receptor (CoStAR™), enhances anti-tumour activity of T cells and tumour infiltrating lymphocytes
    Kalaitsidou, Milena
    Moon, Owen
    Bao, Leyuan
    Dudley, Mark
    Hawkins, Robert
    Kueberuwa, Gray
    Bridgeman, John Stephen
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 467 - 467
  • [4] Investigating the mechanisms by which protective anti-tumour T cell responses are suppressed by Treg cells
    Bowater, J. X.
    Sugiyarto, G.
    Elliott, T. J.
    James, E.
    IMMUNOLOGY, 2014, 143 : 186 - 186
  • [5] Alteration of CD28 signaling motifs increases anti-tumour activity and persistence of chimeric antigen receptor-modified T cells
    Guedan, S.
    Posey, A. D., Jr.
    Wing, A.
    Casado-Medrano, V.
    Shaw, C.
    Young, R. M.
    June, C. H.
    HUMAN GENE THERAPY, 2018, 29 (12) : A118 - A118
  • [6] Dendritic cells pulsed with tumor antigens enhanced the anti-tumour activity of the cytokine stimulated T cells
    Zhang, S
    You, S
    Ge, W
    Ma, S
    Zhao, RC
    EXPERIMENTAL HEMATOLOGY, 2002, 30 (06) : 92 - 92
  • [7] The greater omentum is a unique immune organ which accumulates distinct cytotoxic T cells with anti-tumour properties
    O'Connor, D-B.
    O'Shea, D.
    O'Farrelly, C.
    Lynch, L.
    Winter, D-C.
    BRITISH JOURNAL OF SURGERY, 2010, 97 : S24 - S24
  • [8] Effect of Rituximab On the Activity of T Cells Expressing CD20-Specific Chimeric Antigen Receptors
    Rufener, Gregory A.
    Jensen, Michael C.
    Brouns, Shaunda
    Budde, Lihua E.
    Maloney, David G.
    Press, Oliver W.
    Till, Brian G.
    BLOOD, 2012, 120 (21)
  • [9] Anti-tumour effect of the fourth-generation chimeric antigen receptor T cells targeting CD133 against cholangiocarcinoma cells
    Sangsuwannukul, Thanich
    Supimon, Kamonlapat
    Sujjitjoon, Jatuporn
    Phanthaphol, Nattaporn
    Chieochansin, Thaweesak
    Poungvarin, Naravat
    Wongkham, Sopit
    Junking, Mutita
    Yenchitsomanus, Pa-thai
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 89
  • [10] Expansion of T cells expressing inhibitory natural killer receptors in patients with rheumatoid arthritis in clinical remission following anti-tumour necrosis factor-alpha therapy
    Walsh, C. A. E.
    O'Farrelly, C.
    Golden-Mason, L.
    Veale, D. J.
    FitzGerald, O.
    Bresnihan, B.
    Fearon, U.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 468 - 468
12345